Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntington's Disease

Journal of Neuroscience - United States
doi 10.1523/jneurosci.4008-12.2012
Full Text
Abstract

Available in full text

Categories
Neuroscience
Date
Authors
Publisher

Society for Neuroscience

Related search

Peripheral CB1 Cannabinoid Receptor Blockade Improves Cardiometabolic Risk in Mouse Models of Obesity

Journal of Clinical Investigation
Medicine
2010English

Huntington's Disease: Prenatal Screening for Late Onset Disease.

Journal of Medical Ethics
ArtsHumanitiesLegal AspectsHealth PolicyHealthEthicsIssues
1992English

Cannabinoid Ligand-Receptor Signaling in the Mouse Uterus.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1995English

Corticosterone Dysregulation Exacerbates Disease Progression in the R6/2 Transgenic Mouse Model of Huntington's Disease

Experimental Neurology
Developmental NeuroscienceNeurology
2016English

GFAP Expression as an Indicator of Disease Severity in Mouse Models of Alexander Disease

ASN Neuro
NeuroscienceNeurology
2013English

Multiple Sources of Striatal Inhibition Are Differentially Affected in Huntington's Disease Mouse Models

Journal of Neuroscience
Neuroscience
2013English

Molecular Analysis of Late Onset Huntington's Disease.

Journal of Medical Genetics
Genetics
1993English

Network Spread Determines Severity of Degeneration and Disconnection in Huntington's Disease

Human Brain Mapping
Nuclear MedicineRadiologyUltrasound TechnologyAnatomyRadiologicalNeurologyImaging
2019English

Dysfunctional Dopaminergic Neurones in Mouse Models of Huntington's Disease: A Role for SK3 Channels

Neurodegenerative Diseases
Neurology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy